Stonebridge Wealth Management’s Sanara MedTech SMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-129,452
Closed -$3.05M – 36
2026
Q2
$3.05M Sell
129,452
-7,447
-5% -$154K 2.73% 11
2026
Q1
$2.35M Buy
136,899
+1,965
+1% +$40.4K 2.25% 13
2025
Q4
$3.15M Buy
134,934
+20,353
+18% +$526K 2.98% 10
2025
Q3
$3.64M Sell
114,581
-5,082
-4% -$153K 3.12% 11
2025
Q2
$3.4M Buy
+119,663
New +$3.59M 3.2% 10

Other funds holding SMTI

Stonebridge Wealth Management's SMTI Position: Q3 2026 in Review

Stonebridge Wealth Management sold out of Sanara MedTech (SMTI) in Q3 2026, closing a stake of 129,452 shares — an estimated $3.05M sold.

Stonebridge Wealth Management first reported a position in SMTI in Q2 2025 and held it in 5 quarters. The position peaked at $3.64M in Q3 2025. 36 funds tracked by Wall St. Rank hold SMTI as of Q3 2026.

  • Stonebridge Wealth Management reported no remaining Sanara MedTech position as of Q3 2026 after selling out during the quarter.
  • Stonebridge Wealth Management sold 129,452 Sanara MedTech shares in Q3 2026, an estimated $3.05M.
  • Stonebridge Wealth Management first reported a position in Sanara MedTech in Q2 2025 and held it in 5 quarters.
  • Stonebridge Wealth Management's Sanara MedTech position peaked at $3.64M in Q3 2025.
  • 36 funds tracked by Wall St. Rank held Sanara MedTech as of Q3 2026.

Based on Stonebridge Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.